Trending Now
Selos Therapeutics Inc. (NASDAQ: SEEL) Receives FDA Approval For IND To...
Selos Therapeutics Inc. (NASDAQ: SEEL) has announced that the FDA has accepted its Investigational New Drug application to evaluate SLS-005 (trehalose injection, 90.5mg/mL for...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
ISWH Heats Up as New Bitcoin Play
Bitcoin is rampaging higher, but it doesn’t come as much of a surprise to insiders in the space who have been looking...
MAKE IT MODERN
LATEST REVIEWS
Iterum Therapeutics plc (NASDAQ:ITRM) Submits New Drug Application For Oral Sulopenem...
Iterum Therapeutics plc (NASDAQ:ITRM) has announced the submission of a New Drug Application to the US FDA for sulopenem etzadroxil/probenecid. The application is for...
MAKE IT MODERN
PERFORMANCE TRAINING
Anavex Life Sciences Corp (NASDAQ:AVXL) Receives Notice Of Allowance From USPTO Expanding ANAVEX®2-73 Claims...
Anavex Life Sciences Corp (NASDAQ:AVXL) has announced that the United States Patent and trademark Officer (USPTO) has granted it a Notice of...
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Tolerability And Safety Of AT-301 In Clinical Trial Phase...
Atossa Therapeutics Inc (NASDAQ:ATOS) reported positive results from the Phase 1 clinical trial of its innovative drug candidate AT-301. Currently, no FDA-approved treatments are...
Unusual call activity (GIS, DBX, DDOG, X)
The stock market has opened up today on a positive note. Wall Street is currently eyeing SPY January 6 $324 Calls. If...
Nantkwest Inc (NASDAQ:NK) And ImmunityBio Jointly Announce Initial Patient Dosing In Phase 1 Clinical...
Nantkwest Inc (NASDAQ:NK) and ImmunityBio recently announced an important milestone in the development of their second generation COVID-19 vaccine called hAd5-COVID-19.
The two companies revealed...
NanoString Technologies Inc (NASDAQ:NSTG) Gears Up For Its Q3 2020 Earnings Call And Operating...
NanoString Technologies Inc (NASDAQ:NSTG) recently announced that it plans to release its third-quarter 2020 operating data on November 9, 2020, which is the date...
MAKE IT MODERN
